That's why we never send updates during major holidays. The explanations don't placate Wakefield and others. Well, they don't. In the meantime, they make their professional reputations off us by publishing papers in scientific journals that we never see, while the drug companies that benefited from the research on us make millions upon millions of dollars. The debate about adult growth hormone replacement therapy symbolizes the discontent many hGH recipients express about the NIH's lack of support.
Evidence suggests that hGH-deficient adults suffer chronic health problems.
In 1996, the FDA approved hGH for adults with a pituitary disease or a tumor causing growth-hormone deficiency. It has also developed a wide popularity as a reputed anti-aging drug. Like Randy Wakefield, she had injections of naturally derived hGH when she was young. But shortly after she turned 32, Carter began having difficulty functioning. She had to give up her job at K-Mart because she didn't have the energy to leave the house.